Cancer Drugs Market Research Reports

"...... , there are several manufacturers in the Capecitabine market in China. According to CRI's market research, the sales of Capecitabine in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the COVID-19 pandem......"

"...... 2007. By 2020, Temozolomide has been included in China's Class B medical insurance. There are many manufacturers in the Chinese market in 2020, among which Merck Sharp & Dohme Ltd is the main manufacturer. According to CRI's market ......"

"...... 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included such as United States, China, Japan, India, Korea......"

"...... d high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroendocrine Carcinoma Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and ......"

"...... lysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hematological Malignancies Disease market to help players in achieving a strong market position. Buyers of the report can access v......"

"...... alysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Cancer Targeted Therapy industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis ......"

"...... million in 2020. Over the next five years the Topotecan Hydrochloride market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market......"

"...... d DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. I......"

"...... r the next five years the Mitomycin C market will register a -2.3% CAGR in terms of revenue, the global market size will reach US$ 96.3 million by 2026. This report presents a comprehensive overview, market shares, and growth opportuni......"

"...... VAR and STIVARGA are approved for the treatment of the disease. The incidence rate of hepatic cancer such as intrahepatic bile duct cancer in U.S. was approximately 39,230 during 2017. The risk factors associated with hepatocellular carcinoma ......"